998686
Last Update Posted: 2010-08-11
Recruiting has ended
All Genders accepted | 18 Years-85 Years |
650 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
The purpose of this study is to demonstrate the safety and tolerability of dutogliptin over 52 weeks.
Eligibility
Relevant conditions:
Type 2 Diabetes Mellitus
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov